Harbor Capital Advisors’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Other funds holding CSTL
Harbor Capital Advisors's CSTL Position: Q3 2026 in Review
Harbor Capital Advisors reduced its Castle Biosciences (CSTL) stake by 18% in Q3 2026, selling an estimated $171K and leaving 26,072 shares worth $926K. The position accounts for 0.06% of the portfolio, ranked #360.
Harbor Capital Advisors first reported a position in CSTL in Q2 2023 and has held it in 14 quarters since. The position peaked at $4.39M in Q3 2024. 94 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.
- Harbor Capital Advisors held 26,072 shares of Castle Biosciences worth $926K as of Q3 2026.
- Harbor Capital Advisors sold 5,676 Castle Biosciences shares in Q3 2026, an estimated $171K.
- Castle Biosciences made up 0.06% of Harbor Capital Advisors's portfolio in Q3 2026, its #360 holding.
- Harbor Capital Advisors first reported a position in Castle Biosciences in Q2 2023 and has held it in 14 quarters since.
- Harbor Capital Advisors's Castle Biosciences position peaked at $4.39M in Q3 2024.
- 94 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.
Based on Harbor Capital Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.